Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 001533 | Other Identifier | EDGE |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Flow controlled ventilation (FCV) is a fairly new mode of mechanical ventilation, consisting of a constant inspiratory and expiratory flow. Inspiration is thus comparable to volume controlled ventilation (VCV). The actively controlled, constant flow during expiration is unique. FCV is known to minimize dissipated energy to the lung [ref] and is therefore supposed to aid in lung protective ventilation.
The VICAR study is designed as a prospective single cohort crossover trial. The intervention consists of a sequence of respiratory modes: baseline pressure controlled ventilation (PCV) during 5 minutes, followed by 30 minutes of FCV with an evone respirator (Ventinova Medical B.V., Eindhoven, The Netherlands) and eventually 30 minutes of VCV. Every participant will receive the intervention. Respiratory rate (RR), positive end-expiratory pressure (PEEP) and inspiratory fraction of oxygen (FiO2) will be held constant. According to the manufacturers guidelines, an I:E ratio of 1:1 will be pursued during FCV. During FCV, the respirator will be set with the same PIP as during baseline PCV. For VCV, the same tidal volume as during baseline PCV will be set.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequential "baseline PCV" - "FCV" - "VCV" | Each participant will be subjected to baseline pressure controlled ventilation (PCV) during 5 minutes, followed by 30 minutes of FCV with an evone respirator (Ventinova Medical B.V., Eindhoven, The Netherlands) and eventually 30 minutes of VCV. Respiratory rate (RR), positive end-expiratory pressure (PEEP) and inspiratory fraction of oxygen (FiO2) will be held constant. According to the manufacturers guidelines, an I:E ratio of 1:1 will be pursued during FCV. During FCV, the respirator will be set with the same PIP as during baseline PCV. For VCV, the same tidal volume as during baseline PCV will be set. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Arterial blood gas (ABG) | Diagnostic Test | Arterial blood gasses will be drawn during baseline PCV, and every 15 minutes during FCV and VCV respectively. pO2 (mmHg), pCO2 (mmHg) and pH will be recorded. |
| Measure | Description | Time Frame |
|---|---|---|
| Arterial oxygen tension, PaO2 (mmHg) | Arterial partial oxygen tension as measured on an arterial blood gas sample. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| P/F ratio or Horowitz index (mmHg) | Ratio of the arterial oxygen tension PaO2 (mmHg) divided by the inspiratory fraction of oxygen FiO2. | Post hoc calculation |
| Measure | Description | Time Frame |
|---|---|---|
| SpO2 (%) | Oxygen saturation as measured by pulse oxymetry. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| FiO2 | Fraction of inspired oxygen as measured by the respirator. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients requiring mechanical ventilation for moderately severe ARDS (P/F ratio 100-200) due to COVID-19 were recruited from a tertiary intensive care unit.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tom Schepens, MD, PhD | University Hospital, Antwerp | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Antwerp University Hospital | Edegem | Antwerp | 2650 | Belgium |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35608696 | Derived | Van Dessel ED, De Meyer GR, Morrison SG, Jorens PG, Schepens T. Flow-controlled ventilation in moderate acute respiratory distress syndrome due to COVID-19: an open-label repeated-measures controlled trial. Intensive Care Med Exp. 2022 May 24;10(1):19. doi: 10.1186/s40635-022-00449-4. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Point-of-care arterial blood gas sampling. The sample will be disposed as biohazard material after analysis is done.
| Recording of hemodynamic monitoring | Other | Hemodynamic parameters (invasive arterial blood pressure (mmHg) and heart rate (beats per minute)) will be recorded every 5 minutes. |
|
| Recording of respiratory monitoring | Other | Tidal volume (ml), respiratory rate (breaths per minute), minute volume (l/min), dynamic compliance (ml/cmH2O), resistance (cmH2O/l/min), plateau pressure (cmH2O), mean airway pressure (cmH2O), positive end-expiratory pressure (cmH2O), peak inspiratory pressure (cmH2O) and fraction of inspired oxygen will be recorded every 5 minutes. |
|
| Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| PEEP (cmH2O) | Positive end-expiratory pressure as measured by the respirator. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| Pmean | Mean airway pressure (cmH2O) as measured by the respirator. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| PaCO2 | Arterial partial tension of carbon dioxide (mmHg) as measured on an arterial blood gas sample. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| MV | Minute volume (l/min) as measured by the respirator. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| TV | Tidal volume (ml) as measured by the respirator. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| RR | Respiratory rate (breaths per minute) as measured by the respirator. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| Pplat | Plateau airway pressure (cmH2O) as measured by the respirator | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| PIP | Peak inspiratory airway pressure (cmH2O) as measured by the respirator. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| ABPsys | Systolic arterial blood pressure (mmHg) as measured by a pressure transducer on an arterial catheter. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| ABPmean | Mean arterial blood pressure (mmHg) as measured by a pressure transducer on an arterial catheter. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| ABPdia | Diastolic arterial blood pressure (mmHg) as measured by a pressure transducer on an arterial catheter. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| HR | Heart rate (beats per minute) as measured on a 5-lead continuous electrocardiogram. | Approximately 1 hour (5 min. PCV + 30min. FCV + 30 min. VCV) |
| ID | Term |
|---|---|
| D053120 | Respiratory Aspiration |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D001784 | Blood Gas Analysis |
| ID | Term |
|---|---|
| D001774 | Blood Chemical Analysis |
| D019963 | Clinical Chemistry Tests |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D012129 | Respiratory Function Tests |
| D003948 | Diagnostic Techniques, Respiratory System |
| D008919 | Investigative Techniques |
Not provided
Not provided